GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » YoY EPS Growth

ReNeuron Group (ReNeuron Group) YoY EPS Growth : 1.59% (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. ReNeuron Group's YoY EPS Growth for the quarter that ended in Sep. 2023 was 1.59%.

ReNeuron Group's Earnings per Share (Diluted) for the six months ended in Sep. 2023 was $-0.06.


ReNeuron Group YoY EPS Growth Historical Data

The historical data trend for ReNeuron Group's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group YoY EPS Growth Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.25 23.58 9.46 44.28 48.66

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.40 -10.75 50.00 54.37 1.59

ReNeuron Group YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

ReNeuron Group's YoY EPS Growth for the fiscal year that ended in Mar. 2023 is calculated as:

YoY EPS Growth (A: Mar. 2023 )
=(Earnings per Share (Diluted) (A: Mar. 2023 )-Earnings per Share (Diluted) (A: Mar. 2022 ))/ | Earnings per Share (Diluted) (A: Mar. 2022 ) |
=(-0.115--0.224)/ | -0.224 |
=48.66 %

ReNeuron Group's YoY EPS Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EPS Growth (Q: Sep. 2023 )
=(Earnings per Share (Diluted) (Q: Sep. 2023 )-Earnings per Share (Diluted) (Q: Sep. 2022 )) / | Earnings per Share (Diluted) (Q: Sep. 2022 )) |
=(-0.062--0.063)/ | -0.063 |
=1.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ReNeuron Group YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group (ReNeuron Group) Business Description

Traded in Other Exchanges
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.